FuGENE develops transfection reagents for DNA and RNA delivery into eukaryotic cells. For more than 30 years, the company has focused on efficient nucleic acid transfer with minimal cellular disruption. Its synthetic, multi-component transfection technologies support gene expression, gene silencing and genome engineering. FuGENE reagents are used for protein production, viral vector generation, cell biology research and functional genomics. They also support CRISPR studies and recombinant protein expression. The portfolio is suitable for routine and difficult-to-transfect cell lines, including primary cells, stem cells and suspension cultures.
The product range includes FuGENE® 4K, FuGENE® HD and FuGENE® 6 DNA transfection reagents. It also includes FuGENE® RX for RNA delivery and FuGENE® SI for siRNA transfection and gene silencing. These technologies support transient transfection, viral production, protein expression and RNA-based experiments. They are compatible with mammalian and insect cell systems. FuGENE reagents support a wide range of nucleic acids and experimental formats. Researchers use them in cell-based assays and molecular biology workflows.
Europa Biosite subsidiaries distribute Southern Biotech products in Belgium, Ireland, Luxemburg, Netherlands, Switzerland and the United Kingdom.
